Anja is Head Regulatory Affairs and deputy CEO.

She provides strategic regulatory support to SFL clients for the development, filing and maintenance of healthcare products, with proven ability to develop and implement regulatory strategies for a broad range of product types, including small molecules, biologics, cell and gene therapies.

Leading international regulatory projects and by interacting with Regulatory Authorities, clients and cross-functional teams on a regular basis, she has gained experience in senior level negotiations and supervises a team of high performing regulatory affairs professionals.

She has extensive knowledge of regulatory procedures and hands-on experience in preparing high quality regulatory documentation, such as CTAs, Meeting Requests, Marketing Authorization Applications and variations.

Anja holds a MSc degree in Biology from Albert-Ludwigs-University Freiburg, Germany. During her studies, she focused on Biochemistry, Cell Biology, Immunology and Pharmacology.